期刊
ACS CHEMICAL BIOLOGY
卷 10, 期 6, 页码 1502-1510出版社
AMER CHEMICAL SOC
DOI: 10.1021/acschembio.5b00009
关键词
-
资金
- National Institutes of Health [1K22CA154600, DK54441, DK105542, K99GM107355]
- European Union [241481 AFFINOM-ICS]
- Federal Ministry of Education and Research [0316177F]
- University of Kassel
- Center for Interdisciplinary Nanostructure Science and Technology (CINSaT) at the University of Kassel
- Heart and Stroke Foundation of Canada
A-Kinase Anchoring Proteins (AKAPs) coordinate complex signaling events by serving as spatiotemporal modulators of cAMP-dependent protein kinase activity in cell. Although AKAPs organize a plethora of diverse pathways, their cellular roles are often elusive due to the dynamic nature Of these signaling complexes. AKAPs can interact with the type I or type II PKA holoenzymes by virtue of high-affinity interactions with the R-subunits. As a means to delineate AKAP-mediated PKA signaling in cells, we sought-to develop isoform-selective disruptors of AKAP signaling. Here, we report the development of conformationally constrained peptides named RI-STapled Anchoring Disruptors (RI-STADs) that target the docking/dimerization domain of the type 1 regulatory subunit of PICA. These high-affinity peptides ate isoform-selective for the RI isoforms, can outcompete binding by the classical AKAP disruptor Ht31, and can selectively displace RI alpha, but not RII alpha, from binding the dual-specific AKAP149 complex. Importantly, these peptides are-cell-permeable and disrupt Type I PICA-mediated phosphorylation events in the context of live cells. Hence, RI-STAD peptides are versatile cellular tool's to selectively probe anchored type I PICA signaling events.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据